TABLE OF CONTENTS

Volume 27, Issue 20 (1 May 2008)

Top

Review

Many roads lead to oncogene-induced senescence

S Courtois-Cox, S L Jones and K Cichowski

Oncogene 27: 2801-2809; advance online publication, January 14, 2008; doi:10.1038/sj.onc.1210950

Top

Original Articles

Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells

S Takano, H Yoshitomi, A Togawa, K Sogawa, T Shida, F Kimura, H Shimizu, T Tomonaga, F Nomura and M Miyazaki

Oncogene 27: 2810-2822; advance online publication, November 26, 2007; doi:10.1038/sj.onc.1210951

Phospholipase Cbold gamma1 regulates the Rap GEF1-Rap1 signalling axis in the control of human prostate carcinoma cell adhesion

J C Peak, N P Jones, S Hobbs, M Katan and S A Eccles

Oncogene 27: 2823-2832; advance online publication, November 26, 2007; doi:10.1038/sj.onc.1210954

The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy

D Y Lee and B Sugden

Oncogene 27: 2833-2842; advance online publication, November 26, 2007; doi:10.1038/sj.onc.1210946

The proline-rich domain in p63 is necessary for the transcriptional and apoptosis-inducing activities of TAp63

E S Helton, J Zhang and X Chen

Oncogene 27: 2843-2850; advance online publication, November 26, 2007; doi:10.1038/sj.onc.1210948

A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase

T Banerjee, J B DuHadaway, P Gaspari, E Sutanto-Ward, D H Munn, A L Mellor, W P Malachowski, G C Prendergast and A J Muller

Oncogene 27: 2851-2857; advance online publication, November 19, 2007; doi:10.1038/sj.onc.1210939

Influence of nucleophosmin/B23 on DNA binding and transcriptional activity of the androgen receptor in prostate cancer cell

L Léotoing, L Meunier, M Manin, C Mauduit, M Decaussin, G Verrijdt, F Claessens, M Benahmed, G Veyssière, L Morel and C Beaudoin

Oncogene 27: 2858-2867; advance online publication, November 26, 2007; doi:10.1038/sj.onc.1210942

Enforced epithelial expression of IGF-1 causes hyperplastic prostate growth while negative selection is requisite for spontaneous metastogenesis

P J Kaplan-Lefko, B W Sutherland, A I Evangelou, D L Hadsell, R J Barrios, B A Foster, F DeMayo and N M Greenberg

Oncogene 27: 2868-2876; advance online publication, November 19, 2007; doi:10.1038/sj.onc.1210943

Reduced expression and tumor suppressor function of the ETS transcription factor ESE-3 in prostate cancer

R Cangemi, A Mensah, V Albertini, A Jain, M Mello-Grand, G Chiorino, C V Catapano and G M Carbone

Oncogene 27: 2877-2885; advance online publication, November 26, 2007; doi:10.1038/sj.onc.1210953

The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros

P A Greif, B Tizazu, A Krause, E Kremmer and S K Bohlander

Oncogene 27: 2886-2896; advance online publication, November 26, 2007; doi:10.1038/sj.onc.1210945

Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria FREE

H S Günther, N O Schmidt, H S Phillips, D Kemming, S Kharbanda, R Soriano, Z Modrusan, H Meissner, M Westphal and K Lamszus

Oncogene 27: 2897-2909; advance online publication, November 26, 2007; doi:10.1038/sj.onc.1210949

Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo

J I Johnsen, L Segerström, A Orrego, L Elfman, M Henriksson, B Kågedal, S Eksborg, B Sveinbjörnsson and P Kogner

Oncogene 27: 2910-2922; advance online publication, November 19, 2007; doi:10.1038/sj.onc.1210938

Top

Short Communications

Loss of p53 or p73 in human papillomavirus type 38 E6 and E7 transgenic mice partially restores the UV-activated cell cycle checkpoints

W Dong, C Arpin, R Accardi, L Gissmann, B S Sylla, J Marvel and M Tommasino

Oncogene 27: 2923-2928; advance online publication, November 19, 2007; doi:10.1038/sj.onc.1210944

Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk

R Schwab, R Bussolari, D Corvetta, O Chayka, G Santilli, J M-M Kwok, G F Amorotti, G P Tonini, L Iacoviello, R Bertorelle, C Menin, M Hubank, B Calabretta and A Sala

Oncogene 27: 2929-2933; advance online publication, November 19, 2007; doi:10.1038/sj.onc.1210947

Constitutive activation of the Raf–MAPK pathway causes negative feedback inhibition of Ras–PI3K–AKT and cellular arrest through the EphA2 receptor

C W Menges and D J McCance

Oncogene 27: 2934-2940; advance online publication, December 3, 2007; doi:10.1038/sj.onc.1210957

Extra navigation

.

naturejobs

ADVERTISEMENT